Cargando…
Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis
Minimal change disease (MCD) is the common type of nephrotic syndrome (NS) in children. Currently, there is an urgent need to explore new treatments because of the significant side effects of long-term use of glucocorticoids and immunosuppressive drugs and the failure to reduce proteinuria in some p...
Autores principales: | Ji, Baowei, Liu, Junchao, Yin, Ye, Xu, Hong, Shen, Qian, Yu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492865/ https://www.ncbi.nlm.nih.gov/pubmed/37689694 http://dx.doi.org/10.1038/s41419-023-06124-0 |
Ejemplares similares
-
Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage
por: Lv, Qianying, et al.
Publicado: (2022) -
Erratum to “Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy”
por: Zhang, Feifei, et al.
Publicado: (2023) -
Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
por: Dai, Rufeng, et al.
Publicado: (2019) -
Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo
por: Rousalova, Ilona, et al.
Publicado: (2013) -
Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)